Imricor establishes the first iCMR site in Switzerland

Latest News

Imricor Medical Systems (ASX: IMR), a global leader in real-time iCMR cardiac ablation products, has announced that the University Hospital Lausanne (CHUV) in Switzerland has submitted a purchase order for the capital equipment required to fit out its new iCMR lab.

The lab is scheduled to open in July. CHUV is the first site to establish an iCMR lab with Imricor in Switzerland.

The site will be a Centre of Excellence for Imricor, where physicians from other hospitals can visit and be trained on real-time iCMR cardiac ablations and other future interventions, as the number of active sites across Europe continues to grow.

Imricor chair and CEO Steve Wedan said, “We are very excited to open the new cardiology-owned iCMR facility at the world-class CHUV in Lausanne. We believe this very important site will be an incubator for new iCMR technologies, and a catalyst for new iCMR adoption across Switzerland and all of Europe. We couldn’t be more thrilled than to work so closely with Professor Schwitter and the great team at CHUV.”